BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34376668)

  • 1. Two parallel pathways connect glutamine metabolism and mTORC1 activity to regulate glutamoptosis.
    Bodineau C; Tomé M; Courtois S; Costa ASH; Sciacovelli M; Rousseau B; Richard E; Vacher P; Parejo-Pérez C; Bessede E; Varon C; Soubeyran P; Frezza C; Murdoch PDS; Villar VH; Durán RV
    Nat Commun; 2021 Aug; 12(1):4814. PubMed ID: 34376668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamine, MTOR and autophagy: a multiconnection relationship.
    Bodineau C; Tomé M; Murdoch PDS; Durán RV
    Autophagy; 2022 Nov; 18(11):2749-2750. PubMed ID: 35470752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamoptosis: A new cell death mechanism inhibited by autophagy during nutritional imbalance.
    Villar VH; Durán RV
    Autophagy; 2017 Jun; 13(6):1078-1079. PubMed ID: 28296535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ability to utilise ammonia as nitrogen source is cell type specific and intricately linked to GDH, AMPK and mTORC1.
    Lie S; Wang T; Forbes B; Proud CG; Petersen J
    Sci Rep; 2019 Feb; 9(1):1461. PubMed ID: 30728400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.
    Wang Y; Xu W; Yan Z; Zhao W; Mi J; Li J; Yan H
    J Exp Clin Cancer Res; 2018 Mar; 37(1):63. PubMed ID: 29554968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamine and asparagine activate mTORC1 independently of Rag GTPases.
    Meng D; Yang Q; Wang H; Melick CH; Navlani R; Frank AR; Jewell JL
    J Biol Chem; 2020 Mar; 295(10):2890-2899. PubMed ID: 32019866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual targeting of androgen receptor and mTORC1 by salinomycin in prostate cancer.
    Mirkheshti N; Park S; Jiang S; Cropper J; Werner SL; Song CS; Chatterjee B
    Oncotarget; 2016 Sep; 7(38):62240-62254. PubMed ID: 27557496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemia.
    Nguyen TL; Nokin MJ; Terés S; Tomé M; Bodineau C; Galmar O; Pasquet JM; Rousseau B; van Liempd S; Falcon-Perez JM; Richard E; Muzotte E; Rezvani HR; Priault M; Bouchecareilh M; Redonnet-Vernhet I; Calvo J; Uzan B; Pflumio F; Fuentes P; Toribio ML; Khatib AM; Soubeyran P; Murdoch PDS; Durán RV
    Mol Oncol; 2021 May; 15(5):1412-1431. PubMed ID: 33314742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exopolysaccharides isolated from Rhizopus nigricans induced colon cancer cell apoptosis in vitro and in vivo via activating the AMPK pathway.
    Lu Y; Zhang X; Wang J; Chen K
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutaminolysis activates Rag-mTORC1 signaling.
    Durán RV; Oppliger W; Robitaille AM; Heiserich L; Skendaj R; Gottlieb E; Hall MN
    Mol Cell; 2012 Aug; 47(3):349-58. PubMed ID: 22749528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.
    Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S
    Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sestrin 2 suppresses cells proliferation through AMPK/mTORC1 pathway activation in colorectal cancer.
    Wei JL; Fang M; Fu ZX; Zhang SR; Guo JB; Wang R; Lv ZB; Xiong YF
    Oncotarget; 2017 Jul; 8(30):49318-49328. PubMed ID: 28525387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMPK Inhibits ULK1-Dependent Autophagosome Formation and Lysosomal Acidification via Distinct Mechanisms.
    Nwadike C; Williamson LE; Gallagher LE; Guan JL; Chan EYW
    Mol Cell Biol; 2018 May; 38(10):. PubMed ID: 29507183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTORC1 inhibition in cancer cells protects from glutaminolysis-mediated apoptosis during nutrient limitation.
    Villar VH; Nguyen TL; Delcroix V; Terés S; Bouchecareilh M; Salin B; Bodineau C; Vacher P; Priault M; Soubeyran P; Durán RV
    Nat Commun; 2017 Jan; 8():14124. PubMed ID: 28112156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DRD3 (dopamine receptor D3) but not DRD2 activates autophagy through MTORC1 inhibition preserving protein synthesis.
    Barroso-Chinea P; Luis-Ravelo D; Fumagallo-Reading F; Castro-Hernandez J; Salas-Hernandez J; Rodriguez-Nuñez J; Febles-Casquero A; Cruz-Muros I; Afonso-Oramas D; Abreu-Gonzalez P; Moratalla R; Millan MJ; Gonzalez-Hernandez T
    Autophagy; 2020 Jul; 16(7):1279-1295. PubMed ID: 31538542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamine metabolism regulates autophagy-dependent mTORC1 reactivation during amino acid starvation.
    Tan HWS; Sim AYL; Long YC
    Nat Commun; 2017 Aug; 8(1):338. PubMed ID: 28835610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMPK activation does not enhance autophagy in neurons in contrast to MTORC1 inhibition: different impact on β-amyloid clearance.
    Benito-Cuesta I; Ordóñez-Gutiérrez L; Wandosell F
    Autophagy; 2021 Mar; 17(3):656-671. PubMed ID: 32075509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deregulated MYC expression induces dependence upon AMPK-related kinase 5.
    Liu L; Ulbrich J; Müller J; Wüstefeld T; Aeberhard L; Kress TR; Muthalagu N; Rycak L; Rudalska R; Moll R; Kempa S; Zender L; Eilers M; Murphy DJ
    Nature; 2012 Mar; 483(7391):608-12. PubMed ID: 22460906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin Mutations.
    Adebayo Michael AO; Ko S; Tao J; Moghe A; Yang H; Xu M; Russell JO; Pradhan-Sundd T; Liu S; Singh S; Poddar M; Monga JS; Liu P; Oertel M; Ranganathan S; Singhi A; Rebouissou S; Zucman-Rossi J; Ribback S; Calvisi D; Qvartskhava N; Görg B; Häussinger D; Chen X; Monga SP
    Cell Metab; 2019 May; 29(5):1135-1150.e6. PubMed ID: 30713111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous Schedules.
    Guichard SM; Curwen J; Bihani T; D'Cruz CM; Yates JW; Grondine M; Howard Z; Davies BR; Bigley G; Klinowska T; Pike KG; Pass M; Chresta CM; Polanska UM; McEwen R; Delpuech O; Green S; Cosulich SC
    Mol Cancer Ther; 2015 Nov; 14(11):2508-18. PubMed ID: 26358751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.